Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OUE HealthcareSGX:5WA EBITDA Margin % is 13.03% as of Dec. 2025, which is 65% below its 10-year median of 37.21. The stock has 8 warning signs investors should review. Among 664 Healthcare Providers & Services companies, OUE Healthcare ranks better than 92.32% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. OUE Healthcare's EBITDA for the
six
months ended in Dec. 2025 was S$10.1 Mil. OUE Healthcare's Revenue for the
six
months ended in Dec. 2025 was S$77.3 Mil. Therefore, OUE Healthcare's EBITDA margin for the quarter that ended in Dec. 2025 was 13.03%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
OUE Healthcare EBITDA Margin % Related Terms
OUE Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for OUE Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:5WA vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, OUE Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OUE Healthcare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, OUE Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where OUE Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OUE Healthcare (SGX:5WA) has a EBITDA Margin % of 13.03% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on OUE Healthcare and its competitors. This is 65% below median its historical median of 37.21. According to the industry distribution chart, OUE Healthcare ranks #51 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 7.7%.
Is OUE Healthcare's EBITDA Margin % too high?
OUE Healthcare's current EBITDA Margin % of 13.03% is 65% below median its 10-year median of 37.21. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. OUE Healthcare's value of 13.03% is 27.3% above this industry median. Based on the distribution chart, OUE Healthcare ranks #51 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does OUE Healthcare's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, OUE Healthcare ranks #51 out of 664 companies for EBITDA Margin %. This places OUE Healthcare in the top 8% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.24. OUE Healthcare's value of 13.03% is 27.3% above this benchmark. While the company's 10-year median is 37.21 vs. the industry median of 10.24, OUE Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OUE Healthcare's current EBITDA Margin % of 13.03% is 27.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on OUE Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OUE Healthcare's current EBITDA Margin % is 13.03%, which is 65% below median its own 10-year median of 37.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OUE Healthcare stock overvalued right now?
Based on GuruFocus' analysis, OUE Healthcare (SGX:5WA) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.03, compared to a current price of S$0.04 — trading 30% above its estimated fair value. The current EBITDA Margin % is 13.03%, which is 65% below median its 10-year median of 37.21 and 27.3% above the Healthcare Providers & Services industry median of 10.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For OUE Healthcare (SGX:5WA), the current EBITDA Margin % is 13.03% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
OUE Healthcare Ltd operates healthcare businesses and investments across Singapore, China (PRC), Myanmar, Indonesia, and Japan, with China (PRC) and Singapore contributing the majority of its revenue. The Group operates through four reportable segments: healthcare operations involving hospitals, clinics, and the supply of medical devices and pharmaceutical products; healthcare assets comprising rental of investment properties and healthcare-related assets; properties under development involving healthcare facilities and integrated mixed-use projects; and investments (FRML).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:5WA has been successfully added to your 
